Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barbour

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
Kidney International|November 21, 2020
Updating the International IgA Nephropathy Prediction Tool for use in childrenSean J Barbour, Rosanna Coppo, Lee Er, et al.
Angewandte Chemie (International Ed. in English)|March 26, 2018
Reversible Switching between Highly Porous and Nonporous Phases of an Interpenetrated Diamondoid Coordination Network That Exhibits Gate-Opening at Methane Storage PressuresQing-Yuan Yang, Prem Lama, Susan Sen, et al.
Chemical Science|April 25, 2025
A new type of C<sub>2</sub>H<sub>2</sub> binding site in a <i>cis</i>-bridging hexafluorosilicate ultramicroporous material that offers trace C<sub>2</sub>H<sub>2</sub> captureBai-Qiao Song, Mei-Yan Gao, Lisa Mercene van Wyk, et al.
Kidney International|August 2, 2024
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsySean J Barbour, Rosanna Coppo, Lee Er, et al.
Kidney International|January 8, 2021
Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progressionIzabella Z A Pawluczyk, Athanasios Didangelos, Sean J Barbour, et al.
Nature Materials|June 18, 2026
Methane storage using metal-dipyrazolate frameworksXiang-Jing Kong, Varvara I Nikolayenko, Alan C Eaby, et al.
Diabetes, Obesity & Metabolism|April 28, 2022
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMONDTaha Sen, Rosalie Scholtes, Peter J Greasley, et al.
Kidney International|December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathyTaewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Chem|November 26, 2021
Breaking the trade-off between selectivity and adsorption capacity for gas separationNaveen Kumar, Soumya Mukherjee, Nathan C Harvey-Reid, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trialDavid Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Kidney International|November 21, 2020
Updating the International IgA Nephropathy Prediction Tool for use in childrenSean J Barbour, Rosanna Coppo, Lee Er, et al.
Angewandte Chemie (International Ed. in English)|March 26, 2018
Reversible Switching between Highly Porous and Nonporous Phases of an Interpenetrated Diamondoid Coordination Network That Exhibits Gate-Opening at Methane Storage PressuresQing-Yuan Yang, Prem Lama, Susan Sen, et al.
Chemical Science|April 25, 2025
A new type of C<sub>2</sub>H<sub>2</sub> binding site in a <i>cis</i>-bridging hexafluorosilicate ultramicroporous material that offers trace C<sub>2</sub>H<sub>2</sub> captureBai-Qiao Song, Mei-Yan Gao, Lisa Mercene van Wyk, et al.
Kidney International|August 2, 2024
Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsySean J Barbour, Rosanna Coppo, Lee Er, et al.
Kidney International|January 8, 2021
Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progressionIzabella Z A Pawluczyk, Athanasios Didangelos, Sean J Barbour, et al.
Nature Materials|June 18, 2026
Methane storage using metal-dipyrazolate frameworksXiang-Jing Kong, Varvara I Nikolayenko, Alan C Eaby, et al.
Diabetes, Obesity & Metabolism|April 28, 2022
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMONDTaha Sen, Rosalie Scholtes, Peter J Greasley, et al.
Kidney International|December 17, 2013
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathyTaewoo Lee, Andrea K Biddle, Sofia Lionaki, et al.
Chem|November 26, 2021
Breaking the trade-off between selectivity and adsorption capacity for gas separationNaveen Kumar, Soumya Mukherjee, Nathan C Harvey-Reid, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trialDavid Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
Pageof 30